Reviews Ultravist


No reviews yet.

Ultravist Drug Description
ULTRAVIST
(iopromide) Injection, for intravenous or intra-arterial use


WARNING: NOT FOR INTRATHECAL USE
Inadvertent intrathecal administration may cause
death, convulsions, cerebral hemorrhage, coma, paralysis, arachnoiditis, acute renal failure, cardiac arrest, seizures, rhabdomyolysis, hyperthermia, and brain edema. [see CONTRAINDICATIONS.]

DRUG DESCRIPTION
ULTRAVIST (iopromide) Injection is a nonionic, water soluble x-ray contrast agent for intravascular administration. Each bottle is to be used as a Pharmacy Bulk Package for dispensing multiple single dose preparations utilizing a suitable
transfer device. The chemical name for iopromide is N,N'-Bis(2,3-dihydroxypropyl)
–2,4,6–triiodo–5– [(methoxyacetyl)amino] –N-methyl–1,3-benzenedicarboxamide.
Iopromide has a molecular weight of 791.12 (iodine content 48.12%).
Iopromide has the following structural formula:








ULTRAVIST Injection is a nonionic, sterile, clear, colorless to slightly yellow,
odorless, pyrogen-free aqueous solution of iopromide, containing 2.42 mg/mL
tromethamine buffer and 0.1 mg/mL edetate calcium disodium stabilizer. ULTRAVIST
Injection Pharmacy Bulk Package is available in three strengths:

240 mg I/mL provides 498.72 mg/mL iopromide,
300 mg I/mL provides 623.4 mg/mL iopromide,
370 mg I/mL provides 768.86 mg/mL iopromide.

During the manufacture of ULTRAVIST Injection, sodium hydroxide or hydrochloric
acid may be added for pH adjustment. ULTRAVIST Injection has a pH of 7.4 (6.5–8)
at 25± 2°C, is sterilized by autoclaving and contains no preservatives.
The iodine concentrations (mg I/mL) available have the following physicochemical
properties:




Property
ULTRAVIST
INJECTION
ULTRAVIST
INJECTION
ULTRAVIST
INJECTION


240 mg I/mL
300 mg I/mL
370 mg I/mL


Osmolality* (mOsmol/kg water) @ 37°C
483
607
774


Osmolarity* (mOsmol/L) @ 37°C
368
428
496


Viscosity (cP) @ 20°C
4.9
9.2
22


  @ 37°C
2.8
4.9
10


Density (g/mL) @ 20°C
1.262
1.330
1.409


  @ 37°C
1.255
1.322
1.399


*Osmolality was measured by vapor-pressure
osmometry. Osmolarity was calculated from the measured osmolal concentrations.



Solutions of ULTRAVIST Injection 240 mg I/mL, 300 mg I/mL and 370 mg I/mL have
osmolalities from approximately 1.1 to 2.7 times that of plasma (285 mOsmol/kg
water).
Last reviewed on RxList: 7/20/2010




Ultravist Drug Description
ULTRAVIST
(iopromide) Injection, for intravenous or intra-arterial use


WARNING: NOT FOR INTRATHECAL USE
Inadvertent intrathecal administration may cause
death, convulsions, cerebral hemorrhage, coma, paralysis, arachnoiditis, acute renal failure, cardiac arrest, seizures, rhabdomyolysis, hyperthermia, and brain edema. [see CONTRAINDICATIONS.]

DRUG DESCRIPTION
ULTRAVIST (iopromide) Injection is a nonionic, water soluble x-ray contrast agent for intravascular administration. Each bottle is to be used as a Pharmacy Bulk Package for dispensing multiple single dose preparations utilizing a suitable
transfer device. The chemical name for iopromide is N,N'-Bis(2,3-dihydroxypropyl)
–2,4,6–triiodo–5– [(methoxyacetyl)amino] –N-methyl–1,3-benzenedicarboxamide.
Iopromide has a molecular weight of 791.12 (iodine content 48.12%).
Iopromide has the following structural formula:








ULTRAVIST Injection is a nonionic, sterile, clear, colorless to slightly yellow,
odorless, pyrogen-free aqueous solution of iopromide, containing 2.42 mg/mL
tromethamine buffer and 0.1 mg/mL edetate calcium disodium stabilizer. ULTRAVIST
Injection Pharmacy Bulk Package is available in three strengths:

240 mg I/mL provides 498.72 mg/mL iopromide,
300 mg I/mL provides 623.4 mg/mL iopromide,
370 mg I/mL provides 768.86 mg/mL iopromide.

During the manufacture of ULTRAVIST Injection, sodium hydroxide or hydrochloric
acid may be added for pH adjustment. ULTRAVIST Injection has a pH of 7.4 (6.5–8)
at 25± 2°C, is sterilized by autoclaving and contains no preservatives.
The iodine concentrations (mg I/mL) available have the following physicochemical
properties:




Property
ULTRAVIST
INJECTION
ULTRAVIST
INJECTION
ULTRAVIST
INJECTION


240 mg I/mL
300 mg I/mL
370 mg I/mL


Osmolality* (mOsmol/kg water) @ 37°C
483
607
774


Osmolarity* (mOsmol/L) @ 37°C
368
428
496


Viscosity (cP) @ 20°C
4.9
9.2
22


  @ 37°C
2.8
4.9
10


Density (g/mL) @ 20°C
1.262
1.330
1.409


  @ 37°C
1.255
1.322
1.399


*Osmolality was measured by vapor-pressure
osmometry. Osmolarity was calculated from the measured osmolal concentrations.



Solutions of ULTRAVIST Injection 240 mg I/mL, 300 mg I/mL and 370 mg I/mL have
osmolalities from approximately 1.1 to 2.7 times that of plasma (285 mOsmol/kg
water).
Last reviewed on RxList: 7/20/2010




Ultravist Drug Description
ULTRAVIST
(iopromide) Injection, for intravenous or intra-arterial use


WARNING: NOT FOR INTRATHECAL USE
Inadvertent intrathecal administration may cause
death, convulsions, cerebral hemorrhage, coma, paralysis, arachnoiditis, acute renal failure, cardiac arrest, seizures, rhabdomyolysis, hyperthermia, and brain edema. [see CONTRAINDICATIONS.]

DRUG DESCRIPTION
ULTRAVIST (iopromide) Injection is a nonionic, water soluble x-ray contrast agent for intravascular administration. Each bottle is to be used as a Pharmacy Bulk Package for dispensing multiple single dose preparations utilizing a suitable
transfer device. The chemical name for iopromide is N,N'-Bis(2,3-dihydroxypropyl)
–2,4,6–triiodo–5– [(methoxyacetyl)amino] –N-methyl–1,3-benzenedicarboxamide.
Iopromide has a molecular weight of 791.12 (iodine content 48.12%).
Iopromide has the following structural formula:








ULTRAVIST Injection is a nonionic, sterile, clear, colorless to slightly yellow,
odorless, pyrogen-free aqueous solution of iopromide, containing 2.42 mg/mL
tromethamine buffer and 0.1 mg/mL edetate calcium disodium stabilizer. ULTRAVIST
Injection Pharmacy Bulk Package is available in three strengths:

240 mg I/mL provides 498.72 mg/mL iopromide,
300 mg I/mL provides 623.4 mg/mL iopromide,
370 mg I/mL provides 768.86 mg/mL iopromide.

During the manufacture of ULTRAVIST Injection, sodium hydroxide or hydrochloric
acid may be added for pH adjustment. ULTRAVIST Injection has a pH of 7.4 (6.5–8)
at 25± 2°C, is sterilized by autoclaving and contains no preservatives.
The iodine concentrations (mg I/mL) available have the following physicochemical
properties:




Property
ULTRAVIST
INJECTION
ULTRAVIST
INJECTION
ULTRAVIST
INJECTION


240 mg I/mL
300 mg I/mL
370 mg I/mL


Osmolality* (mOsmol/kg water) @ 37°C
483
607
774


Osmolarity* (mOsmol/L) @ 37°C
368
428
496


Viscosity (cP) @ 20°C
4.9
9.2
22


  @ 37°C
2.8
4.9
10


Density (g/mL) @ 20°C
1.262
1.330
1.409


  @ 37°C
1.255
1.322
1.399


*Osmolality was measured by vapor-pressure
osmometry. Osmolarity was calculated from the measured osmolal concentrations.



Solutions of ULTRAVIST Injection 240 mg I/mL, 300 mg I/mL and 370 mg I/mL have
osmolalities from approximately 1.1 to 2.7 times that of plasma (285 mOsmol/kg
water).
Last reviewed on RxList: 7/20/2010




Ultravist Drug Description
ULTRAVIST
(iopromide) Injection, for intravenous or intra-arterial use


WARNING: NOT FOR INTRATHECAL USE
Inadvertent intrathecal administration may cause
death, convulsions, cerebral hemorrhage, coma, paralysis, arachnoiditis, acute renal failure, cardiac arrest, seizures, rhabdomyolysis, hyperthermia, and brain edema. [see CONTRAINDICATIONS.]

DRUG DESCRIPTION
ULTRAVIST (iopromide) Injection is a nonionic, water soluble x-ray contrast agent for intravascular administration. Each bottle is to be used as a Pharmacy Bulk Package for dispensing multiple single dose preparations utilizing a suitable
transfer device. The chemical name for iopromide is N,N'-Bis(2,3-dihydroxypropyl)
–2,4,6–triiodo–5– [(methoxyacetyl)amino] –N-methyl–1,3-benzenedicarboxamide.
Iopromide has a molecular weight of 791.12 (iodine content 48.12%).
Iopromide has the following structural formula:








ULTRAVIST Injection is a nonionic, sterile, clear, colorless to slightly yellow,
odorless, pyrogen-free aqueous solution of iopromide, containing 2.42 mg/mL
tromethamine buffer and 0.1 mg/mL edetate calcium disodium stabilizer. ULTRAVIST
Injection Pharmacy Bulk Package is available in three strengths:

240 mg I/mL provides 498.72 mg/mL iopromide,
300 mg I/mL provides 623.4 mg/mL iopromide,
370 mg I/mL provides 768.86 mg/mL iopromide.

During the manufacture of ULTRAVIST Injection, sodium hydroxide or hydrochloric
acid may be added for pH adjustment. ULTRAVIST Injection has a pH of 7.4 (6.5–8)
at 25± 2°C, is sterilized by autoclaving and contains no preservatives.
The iodine concentrations (mg I/mL) available have the following physicochemical
properties:




Property
ULTRAVIST
INJECTION
ULTRAVIST
INJECTION
ULTRAVIST
INJECTION


240 mg I/mL
300 mg I/mL
370 mg I/mL


Osmolality* (mOsmol/kg water) @ 37°C
483
607
774


Osmolarity* (mOsmol/L) @ 37°C
368
428
496


Viscosity (cP) @ 20°C
4.9
9.2
22


  @ 37°C
2.8
4.9
10


Density (g/mL) @ 20°C
1.262
1.330
1.409


  @ 37°C
1.255
1.322
1.399


*Osmolality was measured by vapor-pressure
osmometry. Osmolarity was calculated from the measured osmolal concentrations.



Solutions of ULTRAVIST Injection 240 mg I/mL, 300 mg I/mL and 370 mg I/mL have
osmolalities from approximately 1.1 to 2.7 times that of plasma (285 mOsmol/kg
water).
Last reviewed on RxList: 7/20/2010




Ultravist Drug Description
ULTRAVIST
(iopromide) Injection, for intravenous or intra-arterial use


WARNING: NOT FOR INTRATHECAL USE
Inadvertent intrathecal administration may cause
death, convulsions, cerebral hemorrhage, coma, paralysis, arachnoiditis, acute renal failure, cardiac arrest, seizures, rhabdomyolysis, hyperthermia, and brain edema. [see CONTRAINDICATIONS.]

DRUG DESCRIPTION
ULTRAVIST (iopromide) Injection is a nonionic, water soluble x-ray contrast agent for intravascular administration. Each bottle is to be used as a Pharmacy Bulk Package for dispensing multiple single dose preparations utilizing a suitable
transfer device. The chemical name for iopromide is N,N'-Bis(2,3-dihydroxypropyl)
–2,4,6–triiodo–5– [(methoxyacetyl)amino] –N-methyl–1,3-benzenedicarboxamide.
Iopromide has a molecular weight of 791.12 (iodine content 48.12%).
Iopromide has the following structural formula:








ULTRAVIST Injection is a nonionic, sterile, clear, colorless to slightly yellow,
odorless, pyrogen-free aqueous solution of iopromide, containing 2.42 mg/mL
tromethamine buffer and 0.1 mg/mL edetate calcium disodium stabilizer. ULTRAVIST
Injection Pharmacy Bulk Package is available in three strengths:

240 mg I/mL provides 498.72 mg/mL iopromide,
300 mg I/mL provides 623.4 mg/mL iopromide,
370 mg I/mL provides 768.86 mg/mL iopromide.

During the manufacture of ULTRAVIST Injection, sodium hydroxide or hydrochloric
acid may be added for pH adjustment. ULTRAVIST Injection has a pH of 7.4 (6.5–8)
at 25± 2°C, is sterilized by autoclaving and contains no preservatives.
The iodine concentrations (mg I/mL) available have the following physicochemical
properties:




Property
ULTRAVIST
INJECTION
ULTRAVIST
INJECTION
ULTRAVIST
INJECTION


240 mg I/mL
300 mg I/mL
370 mg I/mL


Osmolality* (mOsmol/kg water) @ 37°C
483
607
774


Osmolarity* (mOsmol/L) @ 37°C
368
428
496


Viscosity (cP) @ 20°C
4.9
9.2
22


  @ 37°C
2.8
4.9
10


Density (g/mL) @ 20°C
1.262
1.330
1.409


  @ 37°C
1.255
1.322
1.399


*Osmolality was measured by vapor-pressure
osmometry. Osmolarity was calculated from the measured osmolal concentrations.



Solutions of ULTRAVIST Injection 240 mg I/mL, 300 mg I/mL and 370 mg I/mL have
osmolalities from approximately 1.1 to 2.7 times that of plasma (285 mOsmol/kg
water).
Last reviewed on RxList: 7/20/2010





Other reviews about Ultravist on wordpress

Allergic Reaction to IV Contrast Case
  by jcm9232
Allergic Reaction to Intravenous Contrast Author: V. Dimov, M.D. Reviewer: S. Randhawa, M.D. A 46-year old CF was undergoing a CT scan of the abdomen for investigation of abdominal pain. PMH DM2, […]



Other reviews about Ultravist on web:

Ultravist - A well-tolerated, low osmolality, low viscosity contrast agent that enables ease of administration and rapid iodine delivery rate. Bayer HealthCare Pharmaceuticals - Ultravist® Contrast Agent


Learn about the prescription medication Ultravist (Iopromide Injection), drug uses, dosage, side effects, drug interactions, warnings, reviews and patient labeling. Ultravist (Iopromide Injection) Drug Information: Uses, Side ...


Accurate, FDA approved Ultravist Injection information for healthcare professionals and patients - brought to you by Drugs.com. Ultravist Injection Official FDA information, side effects and uses.


indications contra-indications dosage side-effects pregnancy overdose identification patient information ultravist ULTRAVIST


ULTRAVIST Injection is contraindicated for intrathecal use. Preparatory dehydration (e.g. prolonged fasting and the administration of a laxative before ULTRAVIST Injection) is ... Bayer HealthCare Pharmaceuticals - Diagnostic Imaging Products


Active Ingredients: insulin aspart; insulin aspart protamine Dose Form Description: suspension Route Description: subcutaneous NovoLog Mix 70/30 Strength Description: 30 units ... Generic NovoLog Mix 70/30,Ultravist,Anafranil,Entaprin,Esimil


HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use ULTRAVIST Injection safely and effectively. WARNING: NOT FOR INTRATHECAL USE


Ultravist 370 Milligrams of Iodine Per Milliliter (mg I/mL): Safety and Efficacy in Computed Tomography of Head and Body Ultravist 370 Milligrams of Iodine Per Milliliter (mg I/mL ...


ULTRAVIST® Berlex Canada : Iopromide : Nonionic Iodinated Radiographic Contrast Medium Action And Clinical Pharmacology: Iopromide is a nonionic iodinated radiographic ... RxMed: Pharmaceutical Information - ULTRAVIST


Find patient medical information for Ultravist Inj on WebMD including its uses, side effects and safety, interactions, pictures, warnings and user ratings. Ultravist Inj : Uses, Side Effects, Interactions, Pictures ...





Featured Reviews

Reviews Ortho Micronor

Ortho Micronor Drug Description ORTHO MICRONOR® (norethindrone) Tablets Patients should be counseled that this product does not protect against HIV infection (AIDS) and other sexually transmitted diseases. DRUG DESCRIPTION What...
Read More  |  Review This
Reviews Relafen

Relafen Drug Description RELAFEN® (nabumetone) Tablets Cardiovascular Risk NSAIDs may cause an increased risk of serious cardiovascular thrombotic events, myocardial infarction, and stroke, which can be fatal. This...
Read More  |  Review This
Reviews Methadone Hydrochloride Tablets

Methadone Hydrochloride Drug Description METHADONE HYDROCHLORIDE TABLETS USP 5 mg, 10 mg Deaths, cardiac and respiratory, have been reported during initiation and conversion of pain patients to methadone treatment from treatment...
Read More  |  Review This
Reviews Hydroxyzine

Vistaril Drug Description VISTARIL® (hydroxyzine pamoate) Capsules and Oral Suspension DRUG DESCRIPTION What are the possible side effects of hydroxyzine (Vistaril)? Get emergency medical help if you have any of these signs...
Read More  |  Review This
Reviews Plasma-Lyte 56 and Dextrose

Plasma-Lyte 56 and Dextrose Drug Description PLASMA-LYTE 56 AND DEXTROSE (dextrose hydrous, sodium chloride, potassium acetate and magnesium acetate tetrahydrate) Injection, Solution DRUG DESCRIPTION Plasma-Lyte® 56 and 5% Dextrose...
Read More  |  Review This
Recent News
59sec - the BEST lead management system around!
We tested 59sec - THE lead management system and we love it. 59sec helps small and medium companies to answer leads in maximum 59 seconds. Why...
MOVEorPAY - our favorite facebook app
We do love MOVEorPAY motivational facebook app, because it is very cool and useful. It makes you finish stuff that you know are good for you, but from various reasons, you never do...
ReviewsAZ is almost ready to be officially launched
yes, we have just a few loose ends to tie and we are ready to go :) meanwhile, I am putting some reviews on the site, so people will not get an empty site at the launch....